european medicines agency glp-1 vision loss recommendation november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 2.0: Where the Next

Explore the latest insights on access, mental health, and off-label use in T1D.

Alo breaks down the SELECT trial data, debunks the "muscle melting" myth with new NIH research, and shares his protocol for protecting lean mass.

Learn the safe version, who should avoid it, and how it compares to actual Ozempic

Several patterns appear consistently: Loss of lean muscle mass Inadequate protein intake Nutrient deficiencies, particularly vitamin D and magnesium This matters because muscle mass plays a direct role in supporting skeletal health

It is given as an injection under the skin (subcutaneously), every 2 weeks or once a month

They are selling you appetite suppression, we're building food freedom, plus Swap #006: Mama Z's 4 Indispensable Kitchen Tips that make a real-food kitchen actually work.